๐Ÿ”ฌDeep Research

PBH โ€” Prestige Consumer Healthcare Inc. ยท catalysts, narrative & risks

ยท5 sourcesPBH forecast โ†’

Prestige Consumer Healthcare Inc. (PBH) โ€” Research Snapshot as of 2026-11-10

Company profile: PBH develops, manufactures, markets, distributes, and sells branded over-the-counter (OTC) health and personal care products, with key brands including Clear Eyes (redness relief) and Dramamine (motion sickness) [1]. It is described as one of the largest pure-play OTC healthcare providers [1]. On the most recent close (9 Nov 2026), the stock traded in a tight cluster across sources at roughly $43โ€“$44 โ€” reported as $44 by Ticker Nerd [2], $42.98 by 24/7 Wall St. [3], and $43.67 by StockAnalysis [4].

Recent Catalysts (last ~1โ€“3 months)


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’